FDA: Breast Implant Safety Studies Will Continue
After two days of testimony on what the FDA should do about troubled long-term safety studies of silicone breast implants, agency officials said the studies would continue.
Perspective of Surgeons continued...
Patients who took time off work and paid their way to testify at the meeting urged the FDA to keep trying to answer questions about the long-term and rare complications of breast implants.
"Not everyone gets sick, but those who do, we pay dearly," said Sharon Schwengler of Phoenix.